Latent autoimmune diabetes in adults (LADA) is characterized by the presence of glutamate decarboxylase autoantibodies (GADA). LADA has intermediate features between type 1 diabetes and type 2 diabetes. In addition, genetic risk factors for both types of diabetes are present in LADA. Nonetheless, evidence about the genetics of LADA in non-European populations is scarce. This study aims to perform a genome-wide association study with a phenome-wide association study of LADA in a southeastern Mexican population. We included 59 patients diagnosed with LADA from a previous study and 3121 individuals without diabetes from the MxGDAR/ENCODAT database. We utilized the GENESIS package in R to perform the genome-wide association study (GWAS) of LADA and PLINK for the phenome-wide association study (PheWAS) of LADA features. Nine polymorphisms reach the nominal association level (1 × 10⁻⁵) in the GWAS. The PheWAS showed that rs7305229 is genome-wide and associated with serum GADA levels in our sample (p = 1.84 × 10⁻⁸). rs7305229 is located downstream of the FAIM2 gene; previous reports associate FAIM2 variants with childhood obesity, body mass index, body adiposity measures, lymphocyte CD8+ activity, and anti-thyroid peroxidase antibodies. Our findings reveal that rs7305229 affects the GADA levels in patients with LADA from southeastern Mexico. More studies are needed to determine if this risk genotype exists in other populations with LADA.

Latent autoimmune diabetes in adults (LADA) is characterized by the presence of glutamate de-carboxylase autoantibodies (GADA). LADA has intermediate features between type 1 diabetes and type 2 diabetes. In addition, genetic risk factors for both types of diabetes are present in LADA. Nonetheless, evidence about the genetics of LADA in non-European populations is scarce. This study aims to perform a genome-wide association study with a phenome-wide association study of LADA in a southeastern Mexican population. We included 59 patients diagnosed with LADA from a previous study and 3121 individuals without diabetes from the MxGDAR/ENCODAT database. We utilized the GENESIS package in R to perform the GWAS of LADA and PLINK for the PheWAS of LADA features. Nine polymorphisms reach the nominal association level (1x10-5) in the GWAS. The PheWAS showed that rs7305229 is genome-wide associated with serum GADA levels in our sample (p=1.84x10-8). rs7305229 is located downstream FAIM2 gene; previous reports associate FAIM2 variants with childhood obesity, body mass index, body adiposity measures, lymphocyte CD8+ activity, and anti-thyroid peroxidase antibodies. Our findings reveal that rs7305229 affects the GADA levels in patients with LADA from southeastern Mexico. More studies are needed to determine if this risk genotype exists in other populations with LADA.

Studies on Carica papaya have focused on addressing challenges in cultivation, postharvest management, and its medicinal properties. Given the extensive volume of information produced, a quantitative analysis is required to clarify the intellectual framework of C. papaya research. This study aims to delineate the scientific landscape of C. papaya, identify research trends in agriculture and food science, and analyze correlations between secondary metabolites and bioactivities using bibliometric analysis. Our analysis examined 6546 documents from 1737 journals, consisting of 6076 articles, 379 reviews, and 91 conference papers. The United States, India, Brazil, and China lead scientific production and maintain robust international partnerships. The main research domains were applied sciences (40.9%), analytical studies (36.6%), and experimental research (16.9%), with topics including postharvest quality, disease resistance, genomic sequencing, and biological activities. A co-occurrence analysis revealed an association between polar leaf extracts and phenolic and flavonoid compounds, which are linked to antioxidant, anticancer, and antimicrobial activities. Furthermore, antioxidant activity was the most frequent finding (945 articles). In conclusion, scientific knowledge of C. papaya primarily comprises studies on the plant genome, crop diseases, and bioactive compounds. Research highlights the plant as a valuable resource for sustainable agriculture, specifically its leaves as a source of novel phytopharmaceuticals.

Medicinal plants are being investigated as a source of compounds with biological activities related to diabetes. The antidiabetic properties of the plant Carica papaya have been reported in experimental models. This study aimed to evaluate the phytochemical composition, antioxidant activity, and inhibitory activity of extracts from C. papaya leaves against α-glucosidase and pancreatic lipase. Plant material was collected in Tabasco, Mexico, and extracted by sequential maceration with solvents of increasing polarity: hexane, dichloromethane, methanol, and methanol:water. The extracts were fractionated by column chromatography, and the most active fractions were selected for further purification. The phytochemical identification of the active compounds was performed, and their structures were elucidated using spectroscopic and spectrometric techniques. The methanolic extract, rich in phenols and flavonoids, showed the highest antioxidant capacity (DPPH: 8.99 mmol TE/g; ABTS: 35.94 mmol RE/g; FRAP: 48.62 mmol Fe²⁺/g). The hydroalcoholic extract exhibited α-glucosidase inhibitory activity (38.44%), and bioassay-guided fractionation led to the identification of clitorin. The dichloromethane extract showed pancreatic lipase inhibition (52.2%), and the most active fraction contained loliolide. These findings demonstrate that C. papaya leaves contain bioactive compounds with antioxidants and digestive enzyme inhibitory activities, suggesting they could be candidates for further research in the management of diabetes.

Studies on Carica papaya have focused on solving challenges related to its cultivation, postharvest management, and medicinal properties. Given the extensive volume of information produced, a quantitative analysis is required to delineate the intellectual framework and development of C. papaya research. This study presents the first comprehensive bibliometric analysis of 45 years of scientific research on C. papaya. Our analysis examined 6,544 documents from 1,737 journals, consisting of 6,076 articles, 379 reviews, and 91 conference papers. The United States, India, Brazil, and China lead scientific production, maintaining robust international partnerships. The main research domains were applied sciences (40.9%), analytical studies (36.6%), and experimental research (16.9%), with topics including postharvest quality, disease resistance, genomic sequencing, and the biological activities of secondary metabolites. A co-occurrence analysis revealed an association between polar leaf extracts and phenolic and flavonoid compounds, which are linked to antioxidant, anticancer, and antimicrobial properties. Furthermore, antioxidant activity was the most frequent finding (945 articles). In conclusion, scientific knowledge of C. papaya primarily comprises studies on the plant genome, crop diseases, and bioactive compounds. Research highlights the plant as a valuable resource for sustainable agriculture and, specifically, its leaves as a source of novel phytopharmaceuticals.